SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000936392-03-000457
Filing Date
2003-04-11
Accepted
2003-04-10 18:24:01
Documents
4
Period of Report
2003-05-16
Effectiveness Date
2003-04-11

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT a89038def14a.htm DEF 14A 297266
4 GRAPHIC a89038a8903800.gif GRAPHIC 1706
5 GRAPHIC a89038a8903802.gif GRAPHIC 856
6 GRAPHIC a89038a8903801.gif GRAPHIC 9452
  Complete submission text file 0000936392-03-000457.txt   311166
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24274 | Film No.: 03646169
SIC: 2836 Biological Products, (No Diagnostic Substances)